Naritaka Tamaoki
Gifu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Naritaka Tamaoki.
Journal of Dental Research | 2010
Naritaka Tamaoki; Kazutoshi Takahashi; Takayuki Tanaka; Tomoko Ichisaka; Hitomi Aoki; Tomoko Takeda-Kawaguchi; Kazuki Iida; Takahiro Kunisada; Toshiyuki Shibata; Shinya Yamanaka; Ken-ichi Tezuka
Defined sets of transcriptional factors can reprogram human somatic cells to induced pluripotent stem (iPS) cells. However, many types of human cells are not easily accessible to minimally invasive procedures. Here we evaluated dental pulp cells (DPCs) as an optimal source of iPS cells, since they are easily obtained from extracted teeth and can be expanded under simple culture conditions. From all 6 DPC lines tested with the conventional 3 or 4 reprogramming factors, iPS cells were effectively established from 5 DPC lines. Furthermore, determination of the HLA types of 107 DPC lines revealed 2 lines homozygous for all 3 HLA loci and showed that if an iPS bank is established from these initial pools, the bank will cover approximately 20% of the Japanese population with a perfect match. Analysis of these data demonstrates the promising potential of DPC collections as a source of iPS cell banks for use in regenerative medicine.
PLOS ONE | 2014
Tomoko Takeda-Kawaguchi; Ken Sugiyama; Shunji Chikusa; Kazuki Iida; Hitomi Aoki; Naritaka Tamaoki; Daijiro Hatakeyama; Takahiro Kunisada; Toshiyuki Shibata; Noemi Fusaki; Ken-ichi Tezuka
Human dental pulp cells (hDPCs) are a promising resource for regenerative medicine and tissue engineering and can be used for derivation of induced pluripotent stem cells (iPSCs). However, current protocols use reagents of animal origin (mainly fetal bovine serum, FBS) that carry the potential risk of infectious diseases and unwanted immunogenicity. Here, we report a chemically defined protocol to isolate and maintain the growth and differentiation potential of hDPCs. hDPCs cultured under these conditions showed significantly less primary colony formation than those with FBS. Cell culture under stringently defined conditions revealed a donor-dependent growth capacity; however, once established, the differentiation capabilities of the hDPCs were comparable to those observed with FBS. DNA array analyses indicated that the culture conditions robustly altered hDPC gene expression patterns but, more importantly, had little effect on neither pluripotent gene expression nor the efficiency of iPSC induction. The chemically defined culture conditions described herein are not perfect serum replacements, but can be used for the safe establishment of iPSCs and will find utility in applications for cell-based regenerative medicine.
Journal of Dental Research | 2013
Kazuki Iida; Tomoko Takeda-Kawaguchi; M. Hada; M. Yuriguchi; Hitomi Aoki; Naritaka Tamaoki; Daijiro Hatakeyama; Takahiro Kunisada; Toshiyuki Shibata; Ken-ichi Tezuka
Hypoxia enhances the reprogramming efficiency of human dermal fibroblasts to become induced pluripotent stem cells (iPSCs). Because we showed previously that hypoxia facilitates the isolation and maintenance of human dental pulp cells (DPCs), we examined here whether it promotes the reprogramming of DPCs to become iPSCs. Unlike dermal fibroblasts, early and transient hypoxia (3% O2) induced the transition of DPCs to iPSCs by 3.3- to 5.1-fold compared with normoxia (21% O2). The resulting iPSCs closely resembled embryonic stem cells as well as iPSCs generated in normoxia, as judged by morphology and expression of stem cell markers. However, sustained hypoxia strongly inhibited the appearance of iPSC colonies and altered their morphology, and anti-oxidants failed to suppress this effect. Transient hypoxia increased the expression levels of NANOG and CDH1 and modulated the expression of numerous genes, including those encoding chemokines and their receptors. Therefore, we conclude that hypoxia, when optimized for cell type, is a simple and useful tool to enhance the reprogramming of somatic cells to become iPSCs.
Scientific Reports | 2015
Naritaka Tamaoki; Kazutoshi Takahashi; Hitomi Aoki; Kazuki Iida; Tomoko Kawaguchi; Daijirou Hatakeyama; Masatoshi Inden; Naoyuki Chosa; Akira Ishisaki; Takahiro Kunisada; Toshiyuki Shibata; Naoki Goshima; Shinya Yamanaka; Ken-ichi Tezuka
The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) by defined transcription factors has been a well-established technique and will provide an invaluable resource for regenerative medicine. However, the low reprogramming efficiency of human iPSC is still a limitation for clinical application. Here we showed that the reprogramming potential of human dental pulp cells (DPCs) obtained from immature teeth is much higher than those of mature teeth DPCs. Furthermore, immature teeth DPCs can be reprogrammed by OCT3/4 and SOX2, conversely these two factors are insufficient to convert mature teeth DPCs to pluripotent states. Using a gene expression profiles between these two DPC groups, we identified a new transcript factor, distal-less homeobox 4 (DLX4), which was highly expressed in immature teeth DPCs and significantly promoted human iPSC generation in combination with OCT3/4, SOX2, and KLF4. We further show that activation of TGF-β signaling suppresses the expression of DLX4 in DPCs and impairs the iPSC generation of DPCs. Our findings indicate that DLX4 can functionally replace c-MYC and supports efficient reprogramming of immature teeth DPCs.
Journal of Oral and Maxillofacial Surgery | 2012
Daijiro Hatakeyama; Naritaka Tamaoki; Kazuki Iida; Kazuhiro Yonemoto; Keizo Kato; Hiroki Makita; Makoto Toida; Toshiyuki Shibata
The simple bone cyst is a relatively unusual lesion that occurs in the jaws and in the long bones of the skeleton. In general, the lesion is asymptomatic and often discovered by chance during routine radiographic examination. The nature and etiology have not been established conclusively, and this fact is reflected by the different terms used to describe the condition. These terms include traumatic bone cyst, hemorrhagic bone cyst, solitary bone cyst, and progressive bone cavity. Most simple bone cysts of the jaw are located in the body or symphysis of the mandible. Only a few cases have been reported in the mandibular condyle. This report describes a case of a simple bone cyst in the mandibular condyle in a child. Report of Case The patient was a 6-year-old boy who was referred to the hospital of the Gifu University School of Medicine by his pediatrician for the evaluation and treatment of an asymptomatic lesion in the left mandibular condyle. About 2 weeks previously, the boy had an epileptic seizure. The pediatrician ordered magnetic resonance imaging (MRI) to examine the patient’s brain. MRI displayed no remarkable brain abnormalities but did disclose a cystic lesion of the left mandibular condyle. The patient was a healthy, well-adjusted young boy with no significant medical history except for epilepsy. The patient denied any history of trauma to the maxillofacial region. Physical examination showed no oral or pharyngeal abnormalities and a normal mixed dentition. Jaw excursions were normal, with no swelling, tenderness, and crepitation or clicking of the temporomandibular joints. The maximal jaw-opening distance was 40 mm, with normal motion of the mandible. Laboratory examinations were within normal limits for a 6-year-old boy. The panoramic radiograph showed a cystic radiolucent area placing the left mandibular condyle and extending widely into the mandibular ramus (Fig 1). Computed tomography of the area showed a well-define lesion of 12 12 31 mm extending from the ramus of the mandible to the articular surface of the condyle, without any associated soft tissue swelling (Fig 2). A review of the MR image disclosed a cystic enlargement, with homogeneous intermediate signal intensity on T1-weighted images and homogeneous high signal intensity on T2-weighted images (Fig 3). These findings indicated that a cystic lesion of the left mandibular condyle was a serosanguineous fluidfilled cyst.
Neuroscience Letters | 2015
Daichi Kudo; Masatoshi Inden; Shin-ichiro Sekine; Naritaka Tamaoki; Kazuki Iida; Eiji Naito; Kazuhiro Watanabe; Hiroaki Kamishina; Toshiyuki Shibata; Isao Hozumi
The purpose of this study was to clarify the effect of Chinese propolis on the expression level of neurotrophic factors in dental pulp cells (DPCs). We also investigated that the effects of the conditioned medium (CM) of DPCs stimulated by the propolis against oxidative and endoplasmic reticulum (ER) stresses in human neuroblastoma SH-SY5Y cells, and on neurite extensions in rat adrenal pheochromocytoma PC12 cells. To investigate the effect of the propolis on the levels of neurotrophic factors in DPCs, we performed a qRT-PCR experiment. As results, NGF, but not BDNF and NT-3, in DPCs was significantly elevated by the propolis in a concentration-dependent manner. H2O2-induced cell death was significantly inhibited by the treatment with the CM of DPCs. In addition, the treatment with the propolis-stimulated CM of DPCs had a more protective effect than that with the CM of DPCs. We also examine the effect of the propolis-stimulated CM of DPCs against a tunicamycin-induced ER stress. The treatment with the propolis-stimulated CM as well as the CM of DPCs significantly inhibited tunicamycin-induced cell death. Moreover, the treatment with the propolis-stimulated CM of DPCs significantly induced neurite outgrowth from PC12 cells than that with the CM of DPCs. These results suggest that the CM of DPCs as well as DPCs will be an efficient source of new treatments for neurodegenerative diseases and that the propolis promote the advantage of the CM of DPCs via producing neurotrophic factors.
In Vitro Cellular & Developmental Biology – Animal | 2015
Eiji Naito; Daichi Kudo; Shin-ichiro Sekine; Kazuhiro Watanabe; Yui Kobatake; Naritaka Tamaoki; Masatoshi Inden; Kazuki Iida; Yusuke Ito; Isao Hozumi; Toshiyuki Shibata; Sadatoshi Maeda; Hiroaki Kamishina
Dental pulp cells (DPCs) of various species have been studied for their potentials of differentiation into functional neurons and secretion of neurotrophic factors. In canine, DPCs have only been studied for cell surface markers and differentiation, but there is little direct evidence for therapeutic potentials for neurological disorders. The present study aimed to further characterize canine DPCs (cDPCs), particularly focusing on their neuroregenerative potentials. It was also reported that superparamagnetic iron oxide (SPIO) particles were useful for labeling of MSCs and tracking with magnetic resonance imaging (MRI). Our data suggested that cDPCs hold higher proliferation capacity than bone marrow stromal cells, the other type of mesenchymal stem cells which have been the target of intensive research. Canine DPCs constitutively expressed neural markers, suggesting a close relationship to the nervous system in their developmental origin. Canine DPCs promoted neuritogenesis of PC12 cells, most likely through secretion of neurotrophic factors. Furthermore, SPIO nanoparticles could be effectively transported to cDPCs without significant cytotoxicity and unfavorable effects on neuritogenesis. SPIO-labeled cDPCs embedded in agarose spinal cord phantoms were successfully visualized with a magnetic resonance imaging arousing a hope for noninvasive cell tracking in transplantation studies.
Journal of Bone and Mineral Metabolism | 2018
Ken Sugiyama; Kosuke Nagashima; Takahiro Miwa; Yuta Shimizu; Tomoko Kawaguchi; Kazuki Iida; Naritaka Tamaoki; Daijiro Hatakeyama; Hitomi Aoki; Chikara Abe; Hironobu Morita; Takahiro Kunisada; Toshiyuki Shibata; Hidefumi Fukumitsu; Ken-ichi Tezuka
The central nervous system in adult mammals does not heal spontaneously after spinal cord injury (SCI). However, SCI treatment has been improved recently following the development of cell transplantation therapy. We recently reported that fibroblast growth factor (FGF) 2-pretreated human dental pulp cells (hDPCs) can improve recovery in a rat model of SCI. This study aimed to investigate mechanisms underlying the curative effect of SCI enhanced via FGF2 pretreatment; we selected three hDPC lines upon screening for the presence of mesenchymal stem cell markers and of their functionality in a rat model of SCI, as assessed using the Basso, Beattie, and Bresnahan score of locomotor functional scale, electrophysiological tests, and morphological analyses. We identified FGF2-responsive genes via gene expression analyses in these lines. FGF2 treatment upregulated GABRB1, MMP1, and DRD2, which suggested to contribute to SCI or central the nervous system. In an expanded screening of additional lines, GABRB1 displayed rather unique and interesting behavior; two lines with the lowest sensitivity of GABRB1 to FGF2 treatment displayed an extremely minor effect in the SCI model. These findings provide insights into the role of FGF2-responsive genes, especially GABRB1, in recovery from SCI, using hDPCs treated with FGF2.
Molecular and Clinical Oncology | 2014
Tomomi Yamashita; Keizo Kato; Nguyen Khanh Long; Hiroki Makita; Kazuhiro Yonemoto; Kazuki Iida; Naritaka Tamaoki; Daijiro Hatakeyama; Toshiyuki Shibata
Archive | 2014
Ken-ichi Tezuka; Naritaka Tamaoki; Kazuki Iida; Tomoko Kawaguchi; Hitomi Aoki; Takahiro Kunisada; Toshiyuki Shibata; Naoki Goshima
Collaboration
Dive into the Naritaka Tamaoki's collaboration.
National Institute of Advanced Industrial Science and Technology
View shared research outputs